Alzheimer's

Biotech Company Improves Competitive Awareness and Launch Readiness in Alzheimer’s and Schizophrenia Market

Sedulo GroupCase Studies

In this early‑Alzheimer’s therapeutic space, Sedulo deployed a targeted intelligence initiative combining secondary research and trial data with primary interviews. The result was proactive flagging of competitor R&D moves and potential partnerships, informing strategic planning in a rapidly evolving market.

PAH

Global 2000 Pharma Company Partners with Sedulo for PAH Competitive Landscape Intelligence

Sedulo GroupCase Studies

Leveraging a dual approach of secondary research and Primary Research using Sedulo’s Persistent Source Network™, this project delivered a comprehensive landscape intelligence program for PAH. It mapped evolving competitive pipelines, differentiators, and trial activity to support strategic decision-making in a complex therapeutic area.

Competitor Pricing Analysis

Global Pharma Company Relies on Sedulo’s Competitive Landscape

Sedulo GroupCase Studies

A global pharmaceutical leader partnered with Sedulo Group to gain a clear view of its competitive terrain. Through systematic landscape mapping, analyzing pipelines, trial activity, commercial positioning, and R&D intelligence, Sedulo provided a robust CI foundation. The insights empowered the client to validate strategic assumptions, identify differentiation opportunities, and guide investment priorities with confidence.